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UltrasoundAbstract The differential diagnosis of intramural vascular lesions of the myometrium includes
arteriovenous malformation, gestational trophoblastic neoplasia, hemangiomata, sarcoma, and
interstitial pregnancy. We present a case of irregular uterine bleeding after evacuation of vesicular
mole. The laboratory investigation showed rising serum beta human chorionic gonadotropin levels
(beta HCG). Transvaginal ultrasound and Color Doppler images showed arteriovenous malforma-
tion. These data were consistent with persistent mole.
 2014 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier
B.V. Open access under CC BY-NC-ND license.1. Introduction
Gestational trophoblastic diseases (GTD) present most com-
monly as molar pregnancy in the form of ﬂuid ﬁlled vesicles,
with snow storm appearance on ultrasound. The commonest
symptom being irregular vaginal bleeding preceded by amen-
orrhea. Uterine arteriovenous malformation with GTD is a
very uncommon disorder and can be diagnosed by arteriogra-
phy or color Doppler. Twenty percent of complete moles can
go for invasion. Invasive moles (chorioadenoma destruens)
are locally invasive, rarely metastatic lesions characterized
microscopically by trophoblastic invasion of the myometrium
with identiﬁable villous structures. Patients have persistentvaginal bleeding with elevated beta HCG titers post evacua-
tion. Histopathology is the only conﬁrmatory evidence of inva-
sion. The ﬁrst line of therapy for invasive and persistent moles
is chemotherapy. Invasive moles also have shown to have
spontaneous regression (1,2). Risk factors for developing
GTN after the evacuation of GTD are large theca-lutein cysts
(ovaries >5 cm), extremely enlarged uterus, women above
40 years, previous GTD, and very high HCG levels (3,4). We
present a case of GTD which was diagnosed post evacuation
of vesicular mole as an invasive mole with a unique and unu-
sual morphologic feature of arteriovenous malformation.
2. Case report
A 28 year old female, gravida 1 was admitted to our hospital
with recurrent episodes of bleeding per vagina. She had vesic-
ular mole two months before being treated by suction evacua-
tion outside our hospital. Post evacuation ultrasonography
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level prior to evacuation was 80,000 miu/ml. Tissues were sent
for histopathological examination after dilatation and curet-
tage (D&C) revealing complete mole. Follow up with beta
HCG revealed post evacuation level of 20,000 miu/ml with pla-
teau levels around this level through weekly beta HCG mea-
surements. A private clinic doctor assured her recommending
follow up with alleged ultrasound to be free. At the time of
admission vitals were stable; she was showing no vaginal
bleeding. On per vaginal examination external os was closed.
Uterus was 8 weeks gestational age size. Her hemoglobin was
10 gm%, bleeding and clotting time were normal. Transvagi-
nal ultrasonography (USG) with Color Doppler imaging
showed a highly vascular heterogeneous hyper echoic intramu-
ral mass measuring 3.5 cm · 3 cm size with prominent vessels
in the posterior myometrium separable of the endometrium
that was free .Colour Doppler showed prominent blood ﬂow
signals within and around the lesion suggestive of neovascular-
ization. Pulsed Doppler showed low vascular impedance arte-
rial blood ﬂow. These ﬁndings were suggestive of AV
malformations which raised the suspicion of persistent mole.
Also, left complicated ovarian cyst was evident on ultrasound,
there is intracystic septation and turbid content, it was more
likely a hemorrhagic cyst .i.e. Persistent corpus luteal cyst.
The cyst was 6 · 6 cm (Figs. 1–3). The clinical suspicion of
invasive mole was raised by the myometrial mass with positive
beta HCG after molar evacuation. Also the suspicion was
enforced by the presence of left ovarian theca lutein cyst. Cra-
nial, thoracic, and abdominal computed tomography did not
reveal any evidence of metastatic disease. Oncologist’s opinion
was taken and she was given chemotherapy. She was treated
with a single agent chemotherapy i.e. methotrexate (1 mg/kgFig. 1 Ultrasound showing left ovarian cy
Fig. 2 Transvaginal ultrasound showed an ill deﬁned heterogeneous
away from the endometrium. Ultrasound also showed uterus with embody weight) and folinic acid for 7 days. Thereafter the USG
reports showed a decreasing size of mass and vascularity.
She was followed up weekly till her beta HCG values were
undetectable, thereafter monthly for 6 months, following
which a repeat USG was done, that revealed a normal scan
with no evidence of the mass.3. Discussion
Invasive mole results from the myometrial invasion of a com-
plete or partial mole, which does not show malignancy features
but can metastasize especially to the vagina and lungs (5).
Patients usually present with continuous vaginal bleeding since
prior molar pregnancy or abortion. Myometrial invasion is dif-
ﬁcult to detect on ultrasound as uterine curettage unless there
is a signiﬁcant myometrium invasion. Clinical ﬁndings, beta
HCG and ultrasound all together are necessary for the diagno-
sis (6). Other diagnostic methods are CT scan of chest, brain,
liver and MRI (7).
Acquired uterine arterio-venous malformation is a rare life
threatening condition that must be considered in the differen-
tial diagnosis of sudden, severe vaginal bleeding following uter-
ine curettage (8). They may occur as a late postpartum or post
abortion hemorrhage, due to spontaneous vessel rupture or
triggered by D&C or GTD. Dilatation and curettage is contra-
indicated in emergency as it worsens the condition. This is if a
vascular mass with low resistance ﬂow is seen (8). Transvaginal
Color Doppler ultrasonography has replaced angiography in
the diagnosis, with the latter reserved for cases where inter-
vention is required (9). Ultrasound ﬁndings are nonspeciﬁc
including hypoechoic tubular structures within the myometriumst (left) and normal right ovary (right).
hyper echoic solid lesion with cystic areas seen in the myometrium
pty cavity (left) and vascular intramural mass with AVM (right).
Fig. 3 Color Doppler showing the vasculature of the mass with prominent blood ﬂow signals within the lesion suggestive of
neovascularization. Pulsed Doppler showed low vascular impedance arterial blood ﬂow.
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vessels and ﬂow reversals. 3-dimensional power Doppler
sonography has been used (13). Our case had D&C outside
with the diagnosis of vesicular mole. Doppler ﬂow showed
abnormally dilated vessel channels with heterogeneous mass
suggestive of invasive mole with AVmalformations. High index
of suspicion of acquired AV malformations is important in
avoiding the severe bleeding triggered by D&C. Beta HCG
levels will conﬁrm the diagnosis (14,15).
Successful conservative treatment with chemotherapy is
rarely reported using whether a single agent with methotrexate
or multiagent which includes combinations of methotrexate,
dactinomycin, etoposide, cyclophosphamide and vincristine.
Treatment is continued until the beta HCG level has returned
to normal and then for a further 6 consecutive weeks (16,17).
The need for hysterectomy in a case of GTD in young women
where family is not completed is very limited. Life threatening
hemorrhage is the indication in such a case. Selective emboli-
zation of a complex and large AVM is feasible for the treat-
ment of uterine bleeding and reproductive capability (16–18).
4. Conclusion
Acquired uterine arterio-venous malformations are rare and
life threatening conditions that may be a ﬁnding of persistent
mole and GTD. Recurrent and severe vaginal bleeding can
occur. D&C worsens the situation if not diagnosed properly.
High index of suspicion is important for diagnosis and
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